The acquisition includes 78 properties, a total of about 6.1 million square feet of leasable area, and approximately 17 acres of developmental land.
The $2.7 billion total value includes $2.35 billion for 64 properties and $400 million for 14 properties under development. Thirty-one of the 78 properties, worth $1.3 billion, are subject to rights of first refusal or offer, which, if exercised, may reduce the size of the acquisition or delay the closing.
As part of the transaction, Duke will require HTA to accept seller financing worth $330 million to be paid in three annual principal payments of $110 million beginning in 2018.
More articles on transactions and valuations:
Mayo Clinic to shutter 2 home health facilities in Minnesota
Ascension ends sponsorship of Catholic Health in New York
TeamHealth acquires Synergy Emergency Physicians’ clinical operations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
